Close Menu

Amgen

The firm, beset with rising debt, the ongoing global financial crisis, and a complicated corporate structure, is currently "engaged in negotiations" regarding alternatives to bring in additional cash.

By offering SNP data on warfarin sensitivity, 23andMe may be gearing up to recruit participants for future research projects seeking new gene associations and the clinical utility of pharmacogenomics-guided warfarin dosing.

Decode's Q4 revenues rose 21 percent, but the firm said that it only has enough liquid assets to fund operations into the second quarter of this year.

Some in the clinical genetics community believe the rise of DTC testing offers a prime opportunity to raise awareness of genetics among the general population, despite skepticism about using the tests for clinical decision-making.

New Releases: Mar 25, 2009

Premium

DxS' TheraScreen KRAS Mutation Kit

Jerry Hill, Chad Ziegler, Michael Allen Luther, Drew Harris, Christopher Donovan

DxS get EU approval to sell its TheraScreen K-RAS Mutation Kit for use on Roche's LightCycler instrument and licensed rights to related software.

Updating the HHS Secretary's Advisory Committee on Genetics, Health, and Society regarding New York’s regulatory stance on consumer genomics firms, a health department official said companies that obtain raw data from an analytical testing facility and send a report to an ordering practitioner are considered laboratories.

In opening its new translational research lab, Mass General claims to be "the first and only cancer center" to attempt to molecularly profile all cancer patients that present to the facility.

Seahorse acquired the maker of the SimCell System, a fully integrated cell culture automation system used for selecting clones, optimizing media, and determining the best process conditions for protein manufacturing, for an undisclosed sum. It also raised $6 million in funding from VC investors.

Pages

The US National Institutes of Health's All of Us project awarded $4.6 million to the company Color to develop a genetic counseling resource for the program.

The Times of India reports on a pilot study that used genomic testing to determine whether patients had drug-resistant tuberculosis.

New guidelines say that more women may benefit from genetic testing for hereditary breast or ovarian cancer, according to the Los Angeles Times.

In Cell this week: small proteins identified among human microbiome, role for tumor microbes in pancreatic cancer survival, and more.